Rize Oncology
ON - TorontoBiotechnology
Focus: Rize Oncology is a Toronto-based biotechnology company focused on improving CRISPR efficiency for gene therapy and oncology applications. The company operates as a pre-revenue biotech with a specialized technology platform.
Profile data last refreshed 6h ago · AI intelligence enriched 1mo ago
Open Jobs
1+1 this month
Stable — net +1 jobs in 30d
1 added, 0 removed. Backfill posture.
Should You Work at Rize Oncology?
AI assessmentHigh-risk, high-reward opportunity best suited for technical co-founders or CRISPR specialists willing to join an opaque, very early-stage platform company.
Why Work Here
- Early-stage CRISPR platform company with focus on high-impact oncology and gene therapy, offering equity upside potential for early employees
- Toronto-based location provides access to Canadian biotech talent and research infrastructure
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Interview Prep Quick Facts
Help build intelligence for Rize Oncology
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.